US Stock MarketDetailed Quotes

PHASQ PhaseBio Pharmaceuticals

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose Sep 16 16:00 ET
49.86Market Cap0.00P/E (TTM)

PhaseBio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
-97.99%208K
117K
10.83M
158K
335K
10.34M
0
0
0
0
Operating revenue
-97.99%208K
--117K
--10.83M
--158K
--335K
--10.34M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.70%25.52M
-28.47%18.35M
39.29%118.19M
24.12%32.24M
41.08%28.91M
30.26%31.39M
75.57%25.65M
101.57%84.86M
97.69%25.98M
76.81%20.49M
Selling and administrative expenses
13.81%4.58M
20.50%4.01M
22.91%16.09M
35.39%4.89M
25.00%3.85M
24.15%4.03M
5.32%3.33M
17.00%13.09M
-1.42%3.61M
9.74%3.08M
-General and administrative expense
13.81%4.58M
20.50%4.01M
22.91%16.09M
35.39%4.89M
25.00%3.85M
24.15%4.03M
5.32%3.33M
17.00%13.09M
-1.42%3.61M
9.74%3.08M
Research and development costs
-23.49%20.94M
-35.77%14.34M
41.64%102.11M
22.30%27.36M
43.93%25.07M
31.21%27.37M
94.95%22.32M
133.21%72.09M
166.88%22.37M
92.91%17.42M
Other operating expenses
----
----
----
----
----
----
----
---320K
--0
----
Operating profit
-20.23%-25.31M
28.93%-18.23M
-26.52%-107.36M
-23.51%-32.09M
-39.45%-28.58M
12.64%-21.05M
-79.50%-25.65M
-113.55%-84.86M
-130.30%-25.98M
-76.81%-20.49M
Net non-operating interest income expense
60.24%-99K
48.76%-145K
22.76%-933K
43.52%-183K
39.28%-218K
30.45%-249K
-69.46%-283K
-338.74%-1.21M
-671.43%-324K
-294.05%-359K
Non-operating interest income
240.00%17K
50.00%3K
-94.09%14K
50.00%3K
33.33%4K
-76.19%5K
-99.05%2K
-85.02%237K
-99.38%2K
-99.33%3K
Non-operating interest expense
-54.33%116K
-48.07%148K
-34.46%947K
-42.94%186K
-38.67%222K
-32.98%254K
-24.60%285K
34.29%1.45M
-10.68%326K
36.09%362K
Other net income (expense)
251.39%8.75M
606.44%7.23M
-69.39%-21.18M
-166.17%-10.84M
27.07%-3.13M
-56.73%-5.78M
-217.33%-1.43M
-73,435.29%-12.5M
-45,155.56%-4.07M
-30,757.14%-4.29M
Gain on sale of security
251.39%8.75M
606.44%7.23M
-69.39%-21.18M
-166.17%-10.84M
27.07%-3.13M
-56.73%-5.78M
-217.33%-1.43M
-73,435.29%-12.5M
-45,155.56%-4.07M
-30,757.14%-4.29M
Income before tax
38.46%-16.67M
59.28%-11.14M
-31.36%-129.47M
-41.93%-43.11M
-26.97%-31.92M
3.78%-27.08M
-83.55%-27.36M
-151.14%-98.57M
-168.07%-30.38M
-120.73%-25.14M
Income tax
0
1.6M
0
0
1.6M
0
0
0
Net income
41.89%-16.67M
59.28%-11.14M
-32.98%-131.07M
-41.93%-43.11M
-26.97%-31.92M
-1.91%-28.68M
-83.55%-27.36M
-151.14%-98.57M
-168.07%-30.38M
-120.73%-25.14M
Net income continuous Operations
41.89%-16.67M
59.28%-11.14M
-32.98%-131.07M
-41.93%-43.11M
-26.97%-31.92M
-1.91%-28.68M
-83.55%-27.36M
-151.14%-98.57M
-168.07%-30.38M
-120.73%-25.14M
Minority interest income
Net income attributable to the parent company
41.89%-16.67M
59.28%-11.14M
-32.98%-131.07M
-41.93%-43.11M
-26.97%-31.92M
-1.91%-28.68M
-83.55%-27.36M
-151.14%-98.57M
-168.07%-30.38M
-120.73%-25.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.89%-16.67M
59.28%-11.14M
-32.98%-131.07M
-41.93%-43.11M
-26.97%-31.92M
-1.91%-28.68M
-83.55%-27.36M
-151.14%-98.57M
-168.07%-30.38M
-120.73%-25.14M
Basic earnings per share
43.33%-0.34
73.56%-0.23
12.09%-2.98
12.62%-0.9
23.26%-0.66
38.78%-0.6
-67.31%-0.87
-137.06%-3.39
-164.10%-1.03
-115.00%-0.86
Diluted earnings per share
43.33%-0.34
73.56%-0.23
12.09%-2.98
12.62%-0.9
23.26%-0.66
38.78%-0.6
-67.31%-0.87
-137.06%-3.39
-164.10%-1.03
-115.00%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue -97.99%208K117K10.83M158K335K10.34M0000
Operating revenue -97.99%208K--117K--10.83M--158K--335K--10.34M--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.70%25.52M-28.47%18.35M39.29%118.19M24.12%32.24M41.08%28.91M30.26%31.39M75.57%25.65M101.57%84.86M97.69%25.98M76.81%20.49M
Selling and administrative expenses 13.81%4.58M20.50%4.01M22.91%16.09M35.39%4.89M25.00%3.85M24.15%4.03M5.32%3.33M17.00%13.09M-1.42%3.61M9.74%3.08M
-General and administrative expense 13.81%4.58M20.50%4.01M22.91%16.09M35.39%4.89M25.00%3.85M24.15%4.03M5.32%3.33M17.00%13.09M-1.42%3.61M9.74%3.08M
Research and development costs -23.49%20.94M-35.77%14.34M41.64%102.11M22.30%27.36M43.93%25.07M31.21%27.37M94.95%22.32M133.21%72.09M166.88%22.37M92.91%17.42M
Other operating expenses -------------------------------320K--0----
Operating profit -20.23%-25.31M28.93%-18.23M-26.52%-107.36M-23.51%-32.09M-39.45%-28.58M12.64%-21.05M-79.50%-25.65M-113.55%-84.86M-130.30%-25.98M-76.81%-20.49M
Net non-operating interest income expense 60.24%-99K48.76%-145K22.76%-933K43.52%-183K39.28%-218K30.45%-249K-69.46%-283K-338.74%-1.21M-671.43%-324K-294.05%-359K
Non-operating interest income 240.00%17K50.00%3K-94.09%14K50.00%3K33.33%4K-76.19%5K-99.05%2K-85.02%237K-99.38%2K-99.33%3K
Non-operating interest expense -54.33%116K-48.07%148K-34.46%947K-42.94%186K-38.67%222K-32.98%254K-24.60%285K34.29%1.45M-10.68%326K36.09%362K
Other net income (expense) 251.39%8.75M606.44%7.23M-69.39%-21.18M-166.17%-10.84M27.07%-3.13M-56.73%-5.78M-217.33%-1.43M-73,435.29%-12.5M-45,155.56%-4.07M-30,757.14%-4.29M
Gain on sale of security 251.39%8.75M606.44%7.23M-69.39%-21.18M-166.17%-10.84M27.07%-3.13M-56.73%-5.78M-217.33%-1.43M-73,435.29%-12.5M-45,155.56%-4.07M-30,757.14%-4.29M
Income before tax 38.46%-16.67M59.28%-11.14M-31.36%-129.47M-41.93%-43.11M-26.97%-31.92M3.78%-27.08M-83.55%-27.36M-151.14%-98.57M-168.07%-30.38M-120.73%-25.14M
Income tax 01.6M001.6M000
Net income 41.89%-16.67M59.28%-11.14M-32.98%-131.07M-41.93%-43.11M-26.97%-31.92M-1.91%-28.68M-83.55%-27.36M-151.14%-98.57M-168.07%-30.38M-120.73%-25.14M
Net income continuous Operations 41.89%-16.67M59.28%-11.14M-32.98%-131.07M-41.93%-43.11M-26.97%-31.92M-1.91%-28.68M-83.55%-27.36M-151.14%-98.57M-168.07%-30.38M-120.73%-25.14M
Minority interest income
Net income attributable to the parent company 41.89%-16.67M59.28%-11.14M-32.98%-131.07M-41.93%-43.11M-26.97%-31.92M-1.91%-28.68M-83.55%-27.36M-151.14%-98.57M-168.07%-30.38M-120.73%-25.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.89%-16.67M59.28%-11.14M-32.98%-131.07M-41.93%-43.11M-26.97%-31.92M-1.91%-28.68M-83.55%-27.36M-151.14%-98.57M-168.07%-30.38M-120.73%-25.14M
Basic earnings per share 43.33%-0.3473.56%-0.2312.09%-2.9812.62%-0.923.26%-0.6638.78%-0.6-67.31%-0.87-137.06%-3.39-164.10%-1.03-115.00%-0.86
Diluted earnings per share 43.33%-0.3473.56%-0.2312.09%-2.9812.62%-0.923.26%-0.6638.78%-0.6-67.31%-0.87-137.06%-3.39-164.10%-1.03-115.00%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data